The Week Ahead: Medicine manufacturers and middlemen

For the second time in two weeks, the price of insulin will be under scrutiny on Capitol Hill in the week ahead. On Tuesday, the trio of companies making insulin in the U.S. is due before a House subcommittee that has seized on the diabetes medicine as definitive evidence of prescription drug prices spiraling out…